We are live on ! Find out more
MIH

Meitav Investment House Portfolio holdings

AUM $14.9B
1-Year Est. Return 46.8%
This Fund
S&P 500
This Quarter Est. Return
-13.94%
1 Year Est. Return
+46.8%
3 Year Est. Return
+131.39%
5 Year Est. Return
+140.78%
10 Year Est. Return
AUM
$1.62B
AUM Growth
-$435M
Cap. Flow
-$75.7M
Cap. Flow %
-4.68%
Top 10 Hldgs %
33.88%
Holding
478
New
36
Increased
85
Reduced
177
Closed
142

Sector Composition

Rank Sector Weight
1 Technology 29.3%
2 Healthcare 12.72%
3 Materials 5.4%
4 Communication Services 4.51%
5 Financials 3.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XPO icon
51
XPO
XPO
$23.5B
$10.4M 0.65%
+528,521
New +$14.6M
MPC icon
52
Marathon Petroleum
MPC
$90B
$9.89M 0.61%
+167,580
New +$11.4M
VLO icon
53
Valero Energy
VLO
$90.7B
$9.56M 0.59%
+127,510
New +$11.2M
BIIB icon
54
Biogen
BIIB
$30.6B
$9.39M 0.58%
31,220
-46
-0.1% -$14.7K
OLED icon
55
Universal Display
OLED
$4.16B
$9.09M 0.56%
97,150
+850
+0.9% +$85.8K
MAN icon
56
ManpowerGroup
MAN
$2.63B
$8.27M 0.51%
127,685
+235
+0.2% +$17.9K
ALNY icon
57
Alnylam Pharmaceuticals
ALNY
$29B
$8.14M 0.5%
111,610
-90
-0.1% -$6.92K
CSTE icon
58
Caesarstone
CSTE
$88.2M
$8.07M 0.5%
594,469
+131,141
+28% +$2.04M
MOMO
59
Hello Group
MOMO
$870M
$7.26M 0.45%
+305,700
New +$9.62M
TEVA icon
60
Teva Pharmaceuticals
TEVA
$42.1B
$6.71M 0.42%
435,136
+347,866
+399% +$7.13M
SPY icon
61
State Street SPDR S&P 500 ETF Trust
SPY
$810B
$6.41M 0.4%
33,708
+11,132
+49% +$3M
ELOX
62
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$6.2M 0.38%
12,914
-498
-4% -$275K
DY icon
63
Dycom Industries
DY
$12B
$5.9M 0.36%
109,122
-500
-0.5% -$33.6K
ISRG icon
64
Intuitive Surgical
ISRG
$139B
$4.61M 0.29%
+34,146
New +$5.79M
GLMD icon
65
Galmed Pharmaceuticals
GLMD
$4.9M
$4.46M 0.28%
3,631
-2
-0.1% -$3.49K
INTC icon
66
Intel
INTC
$492B
$4.4M 0.27%
93,949
-34,479
-27% -$1.61M
KMDA icon
67
Kamada
KMDA
$412M
$3.89M 0.24%
882,507
-9,908
-1% -$53.4K
MGIC
68
DELISTED
Magic Software Enterprises
MGIC
$3.61M 0.22%
597,300
+156,416
+35% +$1.28M
AVGO icon
69
Broadcom
AVGO
$2.01T
$3.52M 0.22%
138,490
-62,300
-31% -$1.47M
ORCL icon
70
Oracle
ORCL
$435B
$3.32M 0.21%
73,931
-52,170
-41% -$2.5M
NICE icon
71
Nice
NICE
$6.01B
$3.27M 0.2%
30,829
NTGN
72
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$3.26M 0.2%
648,878
TXN icon
73
Texas Instruments
TXN
$256B
$2.92M 0.18%
30,859
-7,537
-20% -$729K
JNPR
74
DELISTED
Juniper Networks
JNPR
$2.91M 0.18%
107,983
-31,262
-22% -$885K
QCOM icon
75
Qualcomm
QCOM
$170B
$2.85M 0.18%
49,996
-6,979
-12% -$424K

Similar funds

Meitav Investment House's Q4 2018 Portfolio in Review

As of Q4 2018, Meitav Investment House held 478 positions worth $1.62B, down 21% from $2.05B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Meitav Investment House withdrew a net $75.7M in Q4 2018, closing 142 positions and reducing 177 holdings. Its most notable exit was State Street SPDR S&P Aerospace & Defense ETF, an estimated $26.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Healthcare and Materials.

Against the trend, Meitav Investment House opened a new position in KKR & Co worth $20.7M.

  • Meitav Investment House's largest Q4 2018 buy was KKR & Co: 1,053,701 shares worth $20.7M.
  • Meitav Investment House added most to iShares Core S&P 500 ETF in Q4 2018, an estimated $54.1M increase.
  • Meitav Investment House's biggest Q4 2018 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $32M.
  • Meitav Investment House fully exited State Street SPDR S&P Aerospace & Defense ETF in Q4 2018, selling an estimated $26.4M.
  • Meitav Investment House's ten largest holdings make up 34% of its $1.62B portfolio in Q4 2018.
  • Meitav Investment House opened 36 new positions and closed 142 in Q4 2018.
  • Meitav Investment House's portfolio value fell 21% quarter-over-quarter to $1.62B.

Based on Meitav Investment House's 13F filing for Q4 2018, filed 13 Feb 2019.